Report cover image

Global Systemic Anti-Infectives Market Growth (Status and Outlook) 2023-2029

Publisher LP Information, Inc.
Published Jan 27, 2023
Length 122 Pages
SKU # LPI17670189

Description

Global Systemic Anti-Infectives Market Growth (Status and Outlook) 2023-2029

Anti-infective drugs are drugs that have the effect of killing or inhibiting the above pathogenic microorganisms and are applied systemically or topically by oral, intramuscular, intravenous or topical application. Systemic anti-infective drugs are the basic drugs and are widely used in the treatment of bacterial, fungal, chlamydial and viral infections and other infectious complications arising from other diseases.

LPI (LP Information)' newest research report, the “Systemic Anti-Infectives Industry Forecast” looks at past sales and reviews total world Systemic Anti-Infectives sales in 2022, providing a comprehensive analysis by region and market sector of projected Systemic Anti-Infectives sales for 2023 through 2029. With Systemic Anti-Infectives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Systemic Anti-Infectives industry.

This Insight Report provides a comprehensive analysis of the global Systemic Anti-Infectives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Systemic Anti-Infectives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Systemic Anti-Infectives market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Systemic Anti-Infectives and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Systemic Anti-Infectives.

The global Systemic Anti-Infectives market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Systemic Anti-Infectives is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Systemic Anti-Infectives is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Systemic Anti-Infectives is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Systemic Anti-Infectives players cover Pfizer, Sumitomo Dainippon Pharma, MSD, Bayer, Bristol-Myers Squibb, Dechra, Alandalous, Chiatai Tianqing and Hailing Pharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Systemic Anti-Infectives market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Injections
Tablets
Capsules & Pellets
Others

Segmentation by application
Hospital
Clinic
Drugstores
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Sumitomo Dainippon Pharma
MSD
Bayer
Bristol-Myers Squibb
Dechra
Alandalous
Chiatai Tianqing
Hailing Pharm
Southwest Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan
Harbin Pharmaceutical Group
CSPC Pharmaceutical
North China Pharmaceutical
Sinopharm
Luoxin Pharmaceutical
CR Pharma
Duopharma Biotech Group
PT Infion Pharma
Bright-gene

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

122 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Systemic Anti-Infectives Market Size 2018-2029
2.1.2 Systemic Anti-Infectives Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Systemic Anti-Infectives Segment by Type
2.2.1 Injections
2.2.2 Tablets
2.2.3 Capsules & Pellets
2.2.4 Others
2.3 Systemic Anti-Infectives Market Size by Type
2.3.1 Systemic Anti-Infectives Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Systemic Anti-Infectives Market Size Market Share by Type (2018-2023)
2.4 Systemic Anti-Infectives Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Drugstores
2.4.4 Others
2.5 Systemic Anti-Infectives Market Size by Application
2.5.1 Systemic Anti-Infectives Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Systemic Anti-Infectives Market Size Market Share by Application (2018-2023)
3 Systemic Anti-Infectives Market Size by Player
3.1 Systemic Anti-Infectives Market Size Market Share by Players
3.1.1 Global Systemic Anti-Infectives Revenue by Players (2018-2023)
3.1.2 Global Systemic Anti-Infectives Revenue Market Share by Players (2018-2023)
3.2 Global Systemic Anti-Infectives Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Systemic Anti-Infectives by Regions
4.1 Systemic Anti-Infectives Market Size by Regions (2018-2023)
4.2 Americas Systemic Anti-Infectives Market Size Growth (2018-2023)
4.3 APAC Systemic Anti-Infectives Market Size Growth (2018-2023)
4.4 Europe Systemic Anti-Infectives Market Size Growth (2018-2023)
4.5 Middle East & Africa Systemic Anti-Infectives Market Size Growth (2018-2023)
5 Americas
5.1 Americas Systemic Anti-Infectives Market Size by Country (2018-2023)
5.2 Americas Systemic Anti-Infectives Market Size by Type (2018-2023)
5.3 Americas Systemic Anti-Infectives Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Systemic Anti-Infectives Market Size by Region (2018-2023)
6.2 APAC Systemic Anti-Infectives Market Size by Type (2018-2023)
6.3 APAC Systemic Anti-Infectives Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Systemic Anti-Infectives by Country (2018-2023)
7.2 Europe Systemic Anti-Infectives Market Size by Type (2018-2023)
7.3 Europe Systemic Anti-Infectives Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Systemic Anti-Infectives by Region (2018-2023)
8.2 Middle East & Africa Systemic Anti-Infectives Market Size by Type (2018-2023)
8.3 Middle East & Africa Systemic Anti-Infectives Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Systemic Anti-Infectives Market Forecast
10.1 Global Systemic Anti-Infectives Forecast by Regions (2024-2029)
10.1.1 Global Systemic Anti-Infectives Forecast by Regions (2024-2029)
10.1.2 Americas Systemic Anti-Infectives Forecast
10.1.3 APAC Systemic Anti-Infectives Forecast
10.1.4 Europe Systemic Anti-Infectives Forecast
10.1.5 Middle East & Africa Systemic Anti-Infectives Forecast
10.2 Americas Systemic Anti-Infectives Forecast by Country (2024-2029)
10.2.1 United States Systemic Anti-Infectives Market Forecast
10.2.2 Canada Systemic Anti-Infectives Market Forecast
10.2.3 Mexico Systemic Anti-Infectives Market Forecast
10.2.4 Brazil Systemic Anti-Infectives Market Forecast
10.3 APAC Systemic Anti-Infectives Forecast by Region (2024-2029)
10.3.1 China Systemic Anti-Infectives Market Forecast
10.3.2 Japan Systemic Anti-Infectives Market Forecast
10.3.3 Korea Systemic Anti-Infectives Market Forecast
10.3.4 Southeast Asia Systemic Anti-Infectives Market Forecast
10.3.5 India Systemic Anti-Infectives Market Forecast
10.3.6 Australia Systemic Anti-Infectives Market Forecast
10.4 Europe Systemic Anti-Infectives Forecast by Country (2024-2029)
10.4.1 Germany Systemic Anti-Infectives Market Forecast
10.4.2 France Systemic Anti-Infectives Market Forecast
10.4.3 UK Systemic Anti-Infectives Market Forecast
10.4.4 Italy Systemic Anti-Infectives Market Forecast
10.4.5 Russia Systemic Anti-Infectives Market Forecast
10.5 Middle East & Africa Systemic Anti-Infectives Forecast by Region (2024-2029)
10.5.1 Egypt Systemic Anti-Infectives Market Forecast
10.5.2 South Africa Systemic Anti-Infectives Market Forecast
10.5.3 Israel Systemic Anti-Infectives Market Forecast
10.5.4 Turkey Systemic Anti-Infectives Market Forecast
10.5.5 GCC Countries Systemic Anti-Infectives Market Forecast
10.6 Global Systemic Anti-Infectives Forecast by Type (2024-2029)
10.7 Global Systemic Anti-Infectives Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Systemic Anti-Infectives Product Offered
11.1.3 Pfizer Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Sumitomo Dainippon Pharma
11.2.1 Sumitomo Dainippon Pharma Company Information
11.2.2 Sumitomo Dainippon Pharma Systemic Anti-Infectives Product Offered
11.2.3 Sumitomo Dainippon Pharma Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Sumitomo Dainippon Pharma Main Business Overview
11.2.5 Sumitomo Dainippon Pharma Latest Developments
11.3 MSD
11.3.1 MSD Company Information
11.3.2 MSD Systemic Anti-Infectives Product Offered
11.3.3 MSD Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 MSD Main Business Overview
11.3.5 MSD Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Systemic Anti-Infectives Product Offered
11.4.3 Bayer Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Systemic Anti-Infectives Product Offered
11.5.3 Bristol-Myers Squibb Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Dechra
11.6.1 Dechra Company Information
11.6.2 Dechra Systemic Anti-Infectives Product Offered
11.6.3 Dechra Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Dechra Main Business Overview
11.6.5 Dechra Latest Developments
11.7 Alandalous
11.7.1 Alandalous Company Information
11.7.2 Alandalous Systemic Anti-Infectives Product Offered
11.7.3 Alandalous Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Alandalous Main Business Overview
11.7.5 Alandalous Latest Developments
11.8 Chiatai Tianqing
11.8.1 Chiatai Tianqing Company Information
11.8.2 Chiatai Tianqing Systemic Anti-Infectives Product Offered
11.8.3 Chiatai Tianqing Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Chiatai Tianqing Main Business Overview
11.8.5 Chiatai Tianqing Latest Developments
11.9 Hailing Pharm
11.9.1 Hailing Pharm Company Information
11.9.2 Hailing Pharm Systemic Anti-Infectives Product Offered
11.9.3 Hailing Pharm Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Hailing Pharm Main Business Overview
11.9.5 Hailing Pharm Latest Developments
11.10 Southwest Pharmaceutical Co., Ltd.
11.10.1 Southwest Pharmaceutical Co., Ltd. Company Information
11.10.2 Southwest Pharmaceutical Co., Ltd. Systemic Anti-Infectives Product Offered
11.10.3 Southwest Pharmaceutical Co., Ltd. Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Southwest Pharmaceutical Co., Ltd. Main Business Overview
11.10.5 Southwest Pharmaceutical Co., Ltd. Latest Developments
11.11 Guangzhou Baiyunshan
11.11.1 Guangzhou Baiyunshan Company Information
11.11.2 Guangzhou Baiyunshan Systemic Anti-Infectives Product Offered
11.11.3 Guangzhou Baiyunshan Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Guangzhou Baiyunshan Main Business Overview
11.11.5 Guangzhou Baiyunshan Latest Developments
11.12 Harbin Pharmaceutical Group
11.12.1 Harbin Pharmaceutical Group Company Information
11.12.2 Harbin Pharmaceutical Group Systemic Anti-Infectives Product Offered
11.12.3 Harbin Pharmaceutical Group Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Harbin Pharmaceutical Group Main Business Overview
11.12.5 Harbin Pharmaceutical Group Latest Developments
11.13 CSPC Pharmaceutical
11.13.1 CSPC Pharmaceutical Company Information
11.13.2 CSPC Pharmaceutical Systemic Anti-Infectives Product Offered
11.13.3 CSPC Pharmaceutical Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 CSPC Pharmaceutical Main Business Overview
11.13.5 CSPC Pharmaceutical Latest Developments
11.14 North China Pharmaceutical
11.14.1 North China Pharmaceutical Company Information
11.14.2 North China Pharmaceutical Systemic Anti-Infectives Product Offered
11.14.3 North China Pharmaceutical Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 North China Pharmaceutical Main Business Overview
11.14.5 North China Pharmaceutical Latest Developments
11.15 Sinopharm
11.15.1 Sinopharm Company Information
11.15.2 Sinopharm Systemic Anti-Infectives Product Offered
11.15.3 Sinopharm Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Sinopharm Main Business Overview
11.15.5 Sinopharm Latest Developments
11.16 Luoxin Pharmaceutical
11.16.1 Luoxin Pharmaceutical Company Information
11.16.2 Luoxin Pharmaceutical Systemic Anti-Infectives Product Offered
11.16.3 Luoxin Pharmaceutical Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Luoxin Pharmaceutical Main Business Overview
11.16.5 Luoxin Pharmaceutical Latest Developments
11.17 CR Pharma
11.17.1 CR Pharma Company Information
11.17.2 CR Pharma Systemic Anti-Infectives Product Offered
11.17.3 CR Pharma Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 CR Pharma Main Business Overview
11.17.5 CR Pharma Latest Developments
11.18 Duopharma Biotech Group
11.18.1 Duopharma Biotech Group Company Information
11.18.2 Duopharma Biotech Group Systemic Anti-Infectives Product Offered
11.18.3 Duopharma Biotech Group Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Duopharma Biotech Group Main Business Overview
11.18.5 Duopharma Biotech Group Latest Developments
11.19 PT Infion Pharma
11.19.1 PT Infion Pharma Company Information
11.19.2 PT Infion Pharma Systemic Anti-Infectives Product Offered
11.19.3 PT Infion Pharma Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 PT Infion Pharma Main Business Overview
11.19.5 PT Infion Pharma Latest Developments
11.20 Bright-gene
11.20.1 Bright-gene Company Information
11.20.2 Bright-gene Systemic Anti-Infectives Product Offered
11.20.3 Bright-gene Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Bright-gene Main Business Overview
11.20.5 Bright-gene Latest Developments
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us